Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
Cell Tissue Bank ; 23(3): 607-614, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35381893

ABSTRACT

Many congenital malformations often require a multidisciplinary and multistep surgical treatment, including the use of biological membranes. Aims of the study were to describe the use of these membranes for the correction of malformations, their clinical performance at follow-up, and patient's tolerance to them. The study included patients treated between 2009 and November 2020 in two referral centers. They were affected by abdominal wall defects (AWD), esophageal atresia/tracheo-esophageal fistula (EA/TEF), diaphragmatic hernia (CDH), spinal defects (SD), and anorectal malformations (ARM). The human origin membranes used during surgery were amniotic membrane, fascia lata, and pericardium provided by the local tissue bank and the porcine-derived membrane available on the market. Thirty-one patients were retrieved. The sample included 10 AWD, 7 EA/TEF, 5 CDH, 4 SD, 2 ARM, and 3 miscellaneous defects. The median age at repair was 139 days (range: 10,5-1494). The median follow-up was 1021 days (range: 485,5-1535). Two patients were lost at follow-up. The defects were successfully repaired and the membranes perfectly tolerated in 28/29 cases. In 1 case of CDH the fascia lata was replaced with a Goretex patch due to recurrence of the defect. This is the largest series on the use of biological membranes in congenital malformations. The variety of tissues allows to choose the best material for each malformation. The excellent tolerance and performance of this first series of patients encourage the use of these membranes to correct different type of malformations at any age.


Subject(s)
Esophageal Atresia , Hernias, Diaphragmatic, Congenital , Tracheoesophageal Fistula , Animals , Esophageal Atresia/surgery , Hernias, Diaphragmatic, Congenital/surgery , Humans , Retrospective Studies , Swine , Tracheoesophageal Fistula/surgery
2.
Eur Ann Allergy Clin Immunol ; 49(3): 138-142, 2017 May.
Article in English | MEDLINE | ID: mdl-28497678

ABSTRACT

SUMMARY: Rhinitis and sinusitis usually coexist and are concurrent in most individuals; thus, the correct terminology is now "rhinosinusitis". On the basis of numerous causative factors, often co-existing in the same patient, the diagnosis of rhinosinusitis is also made by a wide variety of practitioners (allergologists, otolaryngologists, pulmonologists, primary care physicians, paediatricians, and many others). Approximately 5-15% of the population suffers from chronic rhinosinusitis, and in 10-12% of them, it is of dental origin. The treatment of odontogenic maxillary sinus disease is directed to the management of the rhinosinusitis and of the odontogenic source. The widespread use of dental implants and reconstructive procedures for dental implant placement has led to new types of complication, as in this case report, due to chronic eosinophilic rhinosinusitis secondary to Fusarium infection in the maxillary sinus. The patient was initially evaluated by the allergologist, and subsequently successfully treated by the otolaryngologist with Functional Endoscopic Sinus Surgery. The advantages of endoscopic sinus surgery include more accurate visualization, no external incision, reduced soft tissue dissection, and reduced hospital stay. Chronic maxillary sinusitis of dental origin is a common disease that requires treatment of the sinusitis as well as of the odontogenic source.


Subject(s)
Dental Implants/adverse effects , Fusariosis/diagnosis , Maxillary Sinus , Otolaryngologists , Rhinitis/diagnosis , Sinusitis/diagnosis , Allergy and Immunology , Eosinophils/physiology , Fusariosis/therapy , GPI-Linked Proteins , Humans , Intersectoral Collaboration , Male , Middle Aged , Rhinitis/therapy , Serine Endopeptidases , Sinusitis/therapy
3.
Colorectal Dis ; 18(1): 86-93, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26304756

ABSTRACT

AIM: In paediatric and adult patients with neurogenic bowel, transanal irrigation (TAI) of the colon has gained popularity due to the introduction of a specifically designed device. The aim of this pilot study was to present the results of TAI using the Peristeen(®) TAI system in a group of paediatric patients with anorectal malformation (ARM) and congenital or acquired spinal cord lesions (SCLs). METHOD: Eight Italian paediatric surgery and spina bifida centres participated in the study. The inclusion criteria were age between 6 and 17 years, weight above 20 kg and unsatisfactory bowel management. Patients with chronic inflammatory bowel disease, mental disability and surgery within the previous 3 months were excluded. At the beginning of treatment (T0) and after 3 months (T1) the Bristol scale, a questionnaire assessing bowel function, and two questionnaires on quality of life (QoL) for patients aged 6-11 years (CHQ-pf50) and 12-17 years (SF36) were administered. RESULTS: Eighty-three patients were enrolled, and seventy-eight completed the study (41 ARMs, 37 SCLs). At T1, constipation was reduced in ARMs from 69% to 25.6% and in SCLs from 92.7% to 41.5%, faecal incontinence in ARMs from 50% to 18.6% and in SCLs from 39% to 9.8% and flatus incontinence in ARMs from 20.9% to 9.8% and in SCLs from 31.7% to 10%. At T0, the Bristol Stool Scale types were 1-2 in 45% of ARMs and 77.5% of SCL patients, whereas at T1 types 1-2 were recorded in only 2.5% of SCL patients. QoL improved in both groups. In the younger group, a significant improvement in QoL was recorded in ARM patients for eight of nine variables and in SCL patients for seven of nine variables. CONCLUSION: This study showed that Peristeen TAI resulted in a significant time reduction in colonic cleansing, increased independence from the carer and improved QoL in paediatric patients with ARMs and SCLs.


Subject(s)
Constipation/therapy , Enema/instrumentation , Fecal Incontinence/therapy , Therapeutic Irrigation/instrumentation , Adolescent , Anal Canal/abnormalities , Anorectal Malformations , Anus, Imperforate , Child , Constipation/etiology , Fecal Incontinence/etiology , Female , Gastrointestinal Diseases/etiology , Gastrointestinal Diseases/therapy , Humans , Italy , Male , Pilot Projects , Rectum/abnormalities , Spinal Cord Injuries/complications , Spinal Dysraphism/complications
4.
Pediatr Surg Int ; 31(8): 741-5, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26210660

ABSTRACT

BACKGROUND: Pediatric surgeons and patient organisations agree that fewer centers for anorectal malformations with larger patient numbers are essential to reach better treatment. The European Union transacts a political process which aims to realize such centers of expertise for a multitude of rare diseases. All the centers on a specific rare disease should constitute an ERN on that disease. ARM-Net members in different countries report on first experiences with the implementation of national directives, identifying opportunities and risks of this process. METHODS: Relevant details from the official European legislation were analyzed. A survey among the pediatric surgeons of the multidisciplinary ARM-Net consortium about national implementation was conducted. RESULTS: European legislation calls for multidisciplinary centers treating children with rare diseases, and proposes a multitude of quality criteria. The member states are called to allocate sufficient funding and to execute robust governance and oversight, applying clear methods for evaluation. Participation of the patient organisations is mandatory. The national implementations all over Europe differ a lot in respect of extent and timeframe. CONCLUSIONS: Establishing Centers of Expertise and a ERN for anorectal malformations offers great opportunities for patient care and research. Pediatric surgeons should be actively engaged in this process.


Subject(s)
Anal Canal/abnormalities , Anus, Imperforate/surgery , Health Facilities/standards , Rectum/abnormalities , Anal Canal/surgery , Anorectal Malformations , European Union , Humans , Quality of Health Care , Rectum/surgery
5.
Dis Esophagus ; 26(3): 237-40, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22607127

ABSTRACT

Chronic gastrointestinal symptoms are commonly reported in autistic patients. Dysphagia is often present, and it is generally related to behavioral eating disorders. The association between autism and esophageal achalasia has not been described in literature yet. We report our experience with three cases of autistic children we recently treated for esophageal achalasia. In the first case (a 14-year-old male), achalasia was diagnosed with barium swallow and esophageal manometry and was successfully treated with three pneumatic endoscopic dilatations (follow-up: 3 years). In the second case (a 12-year-old female), achalasia was diagnosed with barium swallow and esophageal manometry and was treated with Heller myotomy after two unsuccessful pneumatic endoscopic attempts (follow-up: 3 months). In the last case, a 15-year-old male underwent barium swallow and endoscopy that confirmed achalasia. He was treated with Heller myotomy, and he is asymptomatic at a 6-month follow-up. To our knowledge, this is the first report of a possible association between autism and esophageal achalasia. Because of the rarity of both diseases, their association in the same patient is unlikely to be casual even if speculation on their common etiology is impossible at present. This finding needs further confirmation, but it is sufficient, in our opinion, to indicate proper evaluation with barium swallow and/or manometry in any autistic children with eating difficulty.


Subject(s)
Autistic Disorder/complications , Esophageal Achalasia/complications , Adolescent , Barium Sulfate , Cardia/surgery , Child , Contrast Media , Deglutition Disorders/etiology , Dilatation/methods , Esophageal Achalasia/diagnostic imaging , Esophageal Achalasia/surgery , Esophageal Achalasia/therapy , Esophageal Sphincter, Lower/physiopathology , Esophagoscopy/methods , Female , Follow-Up Studies , Humans , Laparoscopy/methods , Male , Manometry/methods , Peristalsis/physiology , Radiography
6.
J Plast Reconstr Aesthet Surg ; 76: 57-59, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36513008

ABSTRACT

INTRODUCTION: The introduction of propranolol as systemic therapy for infantile hemangiomas (IH) has changed the natural history of these tumors. Cases presenting with ulceration, functional limitation, and visceral or life-threatening localization are excellent indications to medical therapy. The aim was to report the medium term follow-up after the introduction of propranolol in 3 referral centers with particular attention to outcome and surgical treatments. MATERIALS AND METHODS: In the period 2011-2018 348 patients underwent systemic therapy with propanolol at a mean age of 3.5 months (range 1-10). The indications to begin the treatment were: visceral localization (10,6%), ulceration (20%), risk of severe esthetic impairment (27%), and peri­orifices localization (42.4%). RESULTS: The minimum follow-up was 1 year. Propranolol was administered for a mean of 11 months (range: 6-19) and in 22 cases it was resumed for extra 4.5 months due to rebound. Overall, 97.4% responded to therapy without severe side effects. Seven patients underwent surgery and 9 laser therapy . Twenty-four cases are scheduled for surgery for evident inesthetisms and 4 will undergo laser therapy to complete the treatment. CONCLUSIONS: The use of propranolol has considerably decreased the surgical indications for IH, improved the esthetic and functional outcome, and simplified the definitive surgical treatment. The response rate to therapy is very high and in case of failure both laser and surgery are still very effective. The correct diagnosis, early starting, and adequate duration of therapy are key factors for the success of treatment.


Subject(s)
Hemangioma , Skin Neoplasms , Humans , Infant , Propranolol/therapeutic use , Propranolol/adverse effects , Hemangioma/drug therapy , Treatment Outcome , Administration, Oral , Adrenergic beta-Antagonists/therapeutic use , Adrenergic beta-Antagonists/adverse effects , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology
7.
Int J Obes (Lond) ; 34(8): 1319-27, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20231840

ABSTRACT

AIMS/HYPOTHESIS: Visceral and intermuscular adipose tissue (IMAT) depots account for most obesity-related metabolic and cardiovascular complications. Muscle satellite cells (SCs) are mesenchymal stem cells giving rise to myotubes and also to adipocytes, suggesting their possible contribution to IMAT origin and expansion. We investigated the myogenic differentiation of SCs and the adipogenic potential of both preadipocytes and SCs from genetically obese Zucker rats (fa/fa), focusing on the role of Wnt signaling in these differentiation processes. METHODS: SCs were isolated by single-fiber technique from flexor digitorum brevis muscle and preadipocytes were extracted from subcutaneous adipose tissue (AT). Morphological features and gene expression profile were evaluated during in vitro myogenesis and adipogenesis. Wingless-type MMTV integration site family member 10b (Wnt10b) expression was quantified by quantitative PCR in skeletal muscle and AT. RESULTS: We did not observe any difference in the proliferation rate and in the myogenic differentiation of SCs from obese and lean rats. However, a decreased insulin-induced glucose uptake was present in myotubes originating from fa/fa rats. Under adipogenic conditions, preadipocytes and SCs of obese animals displayed an enhanced adipogenesis. Wnt10b expression was reduced in obese rats in both muscle and AT. CONCLUSIONS/INTERPRETATION: Our data suggest that the increase in different fat depots including IMAT and the reduced muscle insulin sensitivity, the major phenotypical alteration of obese Zucker rats, could be ascribed to an intrinsic defect, either genetically determined or acquired, still present in both muscle and fat precursors. The involvement of Wnt10b as a regulator of both adipogenesis and muscle-to-fat conversion is suggested.


Subject(s)
Adipogenesis/physiology , Adipose Tissue/metabolism , Insulin Resistance/physiology , Obesity/metabolism , Satellite Cells, Skeletal Muscle/cytology , Adipogenesis/genetics , Animals , Cell Differentiation/physiology , Insulin Resistance/genetics , Male , Obesity/genetics , Rats , Rats, Zucker , Satellite Cells, Skeletal Muscle/metabolism
8.
Fetal Diagn Ther ; 24(4): 437-9, 2008.
Article in English | MEDLINE | ID: mdl-19023209

ABSTRACT

Prenatal diagnosis of cloacal exstrophy can be challenging during pregnancy and, subsequently, the counseling very difficult. Available ultrasonographic criteria may be inadequate, especially in early gestational ages. A case of early prenatal detection of cloacal exstrophy with fetal magnetic resonance imaging is reported herein for the first time.


Subject(s)
Abnormalities, Multiple , Cloaca/abnormalities , Magnetic Resonance Imaging , Prenatal Diagnosis/methods , Abortion, Induced , Adult , Early Diagnosis , Female , Gestational Age , Humans , Male , Pregnancy
9.
Pediatr Med Chir ; 30(1): 45-7, 2008.
Article in English | MEDLINE | ID: mdl-18491679

ABSTRACT

Gallbladder polypoid lesions are rare in the pediatric patient and sometimes represent an incidental finding. A 13 year old male was referred to the Padua Hospital Pediatric Department for an obesity. A routine abdominal ultrasound (US) detected a gallbladder polypoid lesion 6 mm in diameter, initially considered a gallbladder adenoma. Investigation did not detect any other biliary tract abnormality. After seven months, the asymptomatic patient underwent a follow-up US which revealed the disappearance of the polypoid mass. The following concerns are raised: what is the size of the polypoid mass that should be considered for surgery? How does the presence of symptoms worsen the diagnosis and lead to preferring a surgical approach (cholecystectomy) over an echographic follow-up?


Subject(s)
Gallbladder Diseases/diagnosis , Polyps/diagnosis , Adolescent , Adult , Diagnosis, Differential , Follow-Up Studies , Gallbladder Diseases/diagnostic imaging , Gallbladder Neoplasms/diagnosis , Gallbladder Neoplasms/diagnostic imaging , Humans , Male , Polyps/diagnostic imaging , Radiography, Abdominal , Remission, Spontaneous , Time Factors , Ultrasonography
10.
Pediatr Med Chir ; 30(5): 258-61, 2008.
Article in Italian | MEDLINE | ID: mdl-19320140

ABSTRACT

Animal bite lesions in the pediatric patient are mainly accounted for by dog bites in 80% to 90% of the cases. They often present a favorable prognosis but serious lesions do account for 5% to 20% of the total incidence. We will present three particular clinical cases which required urgent surgical treatment as well as a review of the current literature to include both medical and surgical treatment methods for this kind of lesion.


Subject(s)
Bites and Stings/surgery , Dogs , Animals , Child , Child, Preschool , Humans , Infant , Injury Severity Score , Male
12.
Eur Rev Med Pharmacol Sci ; 20(13): 2786-91, 2016 07.
Article in English | MEDLINE | ID: mdl-27424976

ABSTRACT

OBJECTIVE: Vestibular disorders and anxiety are closely related, probably because they share some neuronal pathways. Ageing and patient comorbidities are important facilitating factors, and multiple vascular risk factors could contribute to the onset of a vestibular syndrome called vascular vertigo. White matter lesions (WMLs) are often seen on magnetic resonance imaging (MRI) scans of elderly people and are related to various geriatric disorders, including dizziness. The cause of this correlation could be the disruption of neuronal networks that mediate higher vestibular cortical function. Numerous neuronal pathways link the vestibular network with limbic structures and the prefrontal cortex modulates anxiety through its connections to the amygdala. These could also explain nausea and sickness. The aim of the present work was to investigate the correlation between WML, vascular vertigo and cognitive functions. PATIENTS AND METHODS: Our team at the Poliambulanza Foundation Hospital of Brescia studied 90 patients (mean age 75 years) suffering from vascular vertigo with positive WML on MRI, by mapping the lesions and by grading anxiety and sickness symptoms. Furthermore, the same patients were treated with sulodexide (a glycosaminoglycan with antithrombotic activity) for 90 days (500 LSU/day for the first 45 days and 250 LSU/day for the following 45 days) to evaluate the efficacy on the vestibular symptoms. RESULTS: The results showed that the most frequent WML sites were frontal (n=34) and capsule (n=30) areas. Patients had a significant improvement on anxiety and sickness scores (p=0.0001 and p=0.02 respectively) after sulodexide treatment. CONCLUSIONS: In patients with vascular vertigo we confirmed the correlation between dizziness and anxiety and showed preliminary data regarding the efficacy of sulodexide in relieving in these patients anxiety and sickness.


Subject(s)
Magnetic Resonance Imaging , Vertigo/pathology , White Matter/pathology , Aged , Dizziness , Humans
13.
Springerplus ; 5(1): 1623, 2016.
Article in English | MEDLINE | ID: mdl-27722042

ABSTRACT

AIM: Anorectal malformation (ARM) is a rare congenital disorder of the anus and rectum. In the last 30 years virtually all patients born with ARM have survived and surgeons from adult care may be called to deal with new and long-term sequelae, including tumors of the pulled-through anorectum. Two new cases of colorectal carcinoma in young adults born with ARM and a review of the literature is reported to emphasize the importance of a multidisciplinary follow-up. METHODS: A man and a woman, with previous history of ARM, presented at 34 years of age with symptoms of intestinal occlusion and a large pelvic mass. Both patients had no familial history of colorectal carcinoma. RESULTS: The patients underwent biopsies (mucinous rectal adenocarcinoma) and stadiation (T4N0M0). In one case the microsatellite instability showed a stable profile. Despite maximal treatments, including surgery, chemo- and radio-therapy, they both died a few years after diagnosis for progression of disease. CONCLUSION: Case studies are too limited to suggest guidelines for prevention and treatment of such complications, but the life-long follow-up is mandatory in the framework of a well-established network between pediatric and adult surgeons. The risk of tumor development in these patients should not be neglected and colleagues from adult care should be aware of the possibility this occurs in their practice.

14.
J Pediatr Surg ; 50(3): 388-93, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25746694

ABSTRACT

BACKGROUND: CDH is a major birth defect, characterized by high mortality. How the initial defective mesenchymal substructures affects muscle malformation is unclear. Defects of genes involved in diaphragmatic development, such as friend-of-GATA2 (Fog2), may play an important role in its pathogenesis. We investigated the expression of Fog2 and proteins of myogenesis in a series of CDH and in diaphragms at different fetal ages, in order to clarify the role of muscular components during diaphragmatic development in cases with CDH. MATERIAL AND METHODS: Specimen were obtained from seven diaphragms of CDH cases undergoing surgery, 3 entire diaphragms from non repaired CDH, 5 control diaphragms at different gestational ages (16, 17, 22, 32, and 40g.w.), and 3 biopsy samples of normal voluntary muscle. The thickness of diaphragms at the edge of the defect in CDH and in developing diaphragms was measured. All samples were processed for HE staining and immunohistochemistry. Immunohistochemical expression of MyoD, Myf4, Pax7, Mib1 and Fog2 was evaluated. RESULTS: Mean thickness at the edge of the defect was 4.14mm. Contralateral hemi-diaphragm in 3 autopsies and in controls at 32 and 40weeks measured 2.25mm; histology showed a higher density of desmin-positive muscular cells at the edge of defect. CDH displayed scattered Myf4-positive cells (range 0%-10%, mean 2.4%), numerous Pax7-positive cells (range 0%-24%, mean 12.1%) and less than 1% Mib1-positive cells. Controls showed a reduction of positive cell with the progression of gestational age for Myf4 (30% at 16 weeks, 20% at 17 weeks, 5% at 22 weeks, 1% at 32 and 40 weeks), Pax7 (85% at 16 weeks and 17 weeks, 35% at 22 weeks, 11% at 32 weeks) and Mib1 (20% at 16 weeks, 8% at 17 weeks, 7% at 22weeks, 2% at 32 weeks). Fog-2 was diffusely positive in mesenchymal, mesothelial and muscular cells, in diaphragms from 16 to 22 weeks, decreasing to 20% of positive muscular cells in 32-week diaphragm. In CDH only mesothelial and mesenchymal cells were positive. Stem cell markers were negative in cases and controls. COMMENT: CDH shows a thick muscular border, with high number of mature muscle cells and significant increase of quiescent satellite cells (PAX7+, Mib1-). Abnormal architecture may affect the normal process of myogenesis and thus signaling and cell-cell interactions of myocytes. The expression of Fog2 in mesothelial and mesenchymal cells in CDH demonstrates the absence of a genetic defect involving Fog2 in our cases. Being Fog2 expressed in muscle cells at early stage supports the hypothesis that the altered diaphragmatic genesis may undermine also the muscular component instead of the only mesenchymal one.


Subject(s)
Diaphragm/abnormalities , Hernias, Diaphragmatic, Congenital/diagnosis , Muscle Development , Female , Humans , Immunohistochemistry , Infant, Newborn , Male , Prospective Studies
15.
J Pediatr Surg ; 50(9): 1441-56, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25783403

ABSTRACT

BACKGROUND: Our study aims at disclosing epidemiology and most relevant clinical features of esophageal atresia (EA) pointing to a model of multicentre collaboration. METHODS: A detailed questionnaire was sent to all Italian Units of pediatric surgery in order to collect data of patients born with EA between January and December 2012. The results were crosschecked by matching date and place of birth of the patients with those of diagnosis-related group provided by the Italian Ministry of Health (MOH). RESULTS: A total of 146 questionnaires were returned plus a further 32 patients reported in the MOH database. Basing on a total of 178 patients with EA born in Italy in 2012, the incidence of EA was calculated in 3.33 per 10,000 live births. Antenatal diagnosis was suspected in 29.5% patients. 55.5% showed associated anomalies. The most common type of EA was Gross type C (89%). Postoperative complications occurred in 37% of type C EA and 100% of type A EA. A 9.5% mortality rate was reported. CONCLUSIONS: This is the first Italian cross-sectional nationwide survey on EA. We can now develop shared guidelines and provide more reliable prognostic expectations for our patients.


Subject(s)
Esophageal Atresia/epidemiology , Prenatal Diagnosis , Surveys and Questionnaires , Tracheoesophageal Fistula/epidemiology , Adult , Cross-Sectional Studies , Diagnosis-Related Groups , Esophageal Atresia/diagnosis , Female , Humans , Incidence , Infant, Newborn , Italy/epidemiology , Male , Pregnancy , Tracheoesophageal Fistula/diagnosis , Young Adult
16.
J Hypertens ; 19(9): 1675-80, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11564989

ABSTRACT

OBJECTIVE: We have recently observed that in young, normotensive patients with a type I diabetes mellitus and no macro or microvascular complications, large artery structure and function are already altered. This study has been done to assess whether this condition is also characterized by early alterations in cardiac structure and function, and whether these alterations progress with time. DESIGN AND METHODS: In 56 insulin-treated, normotensive uncomplicated type I diabetic patients (age 35.0 +/- 2 years, means +/- SE) in good metabolic control, left ventricular wall thickness and diameter were measured by echocardiography together with left ventricular ejection fraction and diastolic function E/A (ratio between early and late ventricular filling), before and after 23 +/- 1 months. The same measurements were made in 20 age and sex-matched subjects who served as controls (C). RESULTS: Compared to C, diabetic patients had a significant increase in left ventricular wall (septal plus posterior wall) thickness (+ 8.4%), left ventricular mass index (+ 11%) and h/r ratio (left ventricular wall thickness/ventricular end diastolic diameter, + 16.0%) whereas they showed a reduction of E/A (-6%). In C, all echocardiographic values were unchanged after 2 years. This was the case also for diabetic patients, except for left ventricular ejection fraction and diastolic diameter which showed a significant reduction (-7.2%) and increase (+ 3.8%), respectively, with a reduction of ratio between LV wall thickness and diameter, h/r (-6.8%). CONCLUSIONS: Uncomplicated type I diabetes mellitus is characterized by early structural and functional cardiac alterations. Some of these alterations show a measurable progression within a relatively short time span.


Subject(s)
Blood Pressure , Diabetes Mellitus, Type 1/pathology , Diabetes Mellitus, Type 1/physiopathology , Heart/physiopathology , Myocardium/pathology , Adolescent , Adult , Coronary Circulation , Diabetes Mellitus, Type 1/diagnostic imaging , Diastole , Disease Progression , Echocardiography , Heart Ventricles , Humans , Reference Values , Stroke Volume , Time Factors , Ventricular Function, Left
17.
Pediatr Pulmonol ; 30(2): 149-52, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10922138

ABSTRACT

Congenital respiratory tract-biliary fistula, including tracheo- and broncho-biliary fistulae, are rare developmental anomalies. To date, only 18 cases have been reported. We present two additional cases that came to our attention after a long and difficult attempt to make a diagnosis. After surgical excision of the tract both children have remained symptom-free for 6 and 4 years, respectively. Bronchoscopy allows an early diagnosis, but patients also have to be investigated for associated biliary tree malformations.


Subject(s)
Biliary Fistula/congenital , Biliary Tract/abnormalities , Bronchial Fistula/congenital , Tracheal Diseases/congenital , Biliary Fistula/pathology , Biliary Fistula/surgery , Bronchial Fistula/pathology , Bronchial Fistula/surgery , Diagnosis, Differential , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases , Male , Prognosis , Tracheal Diseases/pathology , Tracheal Diseases/surgery
18.
Pediatr Pulmonol ; 35(1): 50-5, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12461739

ABSTRACT

Urokinase is an enzyme with a fibrinolytic effect that facilitates pleural empyema drainage through a chest tube. The aim of this study was to assess the risk of pneumothorax, the need for pleural debridement surgery, the persistence of fever, and the number of days in hospital in a group of children with parapneumonic pleural empyema treated with urokinase. This was an uncontrolled retrospective study on children suffering from parapneumonic empyema. Data collected on 17 children treated with urokinase were compared with 11 children treated prior to the advent of urokinase (the "historic" group). The urokinase was instilled in the pleural cavity over a period ranging from 2-8 days, amounting to a median total dose per kilogram of body weight of 18,556 IU (range, 7,105-40,299). Surgical treatment of the empyema involved drainage tube placement and/or debridement of the pleural cavity. Three children developed pneumothorax during their hospital stay, and one more case occurred 6 months after the child had recovered from his empyema; there were 3 cases of pneumothorax during the acute phase in the "historic" group (P = 0.54). Five children in the urokinase group were debrided and 12 were only drained, as opposed to 9 and 2, respectively, in the "historic" group (P = 0.02). The overall hospital stay was 17 days for the urokinase group, and 24 for the "historic" group (P = 0.02). No bleeding or other major complications were reported in the group treated with urokinase. In conclusion, urokinase treatment does not carry a risk of pneumothorax, while it does reduce hospital stay and the need for pleural debridement.


Subject(s)
Empyema, Pleural/drug therapy , Plasminogen Activators/therapeutic use , Urokinase-Type Plasminogen Activator/therapeutic use , Child , Child, Preschool , Debridement , Empyema, Pleural/complications , Empyema, Pleural/economics , Empyema, Pleural/surgery , Female , Humans , Length of Stay , Male , Plasminogen Activators/economics , Pneumothorax/etiology , Retrospective Studies , Urokinase-Type Plasminogen Activator/economics
19.
Tissue Cell ; 27(3): 339-48, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7645012

ABSTRACT

The ultrastructure of brown adipose tissue (BAT), the thermogenic type of adipose tissue, was investigated in biopsies from 4 pre-term human new-borns delivered at 25-27 week's gestational age and compared with peri-renal brown fat from 2 adult patients with phaeochromocytoma (a condition of brown fat activation). The cell size of brown adipocytes was smaller in pre-term new-borns than in adult patients; adipocytes were almost exclusively multilocular, suggesting active thermogenesis. In 3 of the pre-term new-borns, brown adipocyte ultrastructure indicated a good to high degree of differentiation (in particular at the level of mitochondria) as compared with activated brown fat cells found in adult patients; in one pre-term infant the tissue morphology was obviously suggestive of an earlier, proliferative phase of development and the differentiation process of brown adipocytes could be traced in some detail. The results suggest that (a) brown adipose tissue may be fairly well-differentiated and thermogenetically active in pre-term human new-borns weighing about 750 g at birth; (b) brown adipocytes apparently develop from vessel-associated cells, the early signs of adipocyte differentiation being glycogen and lipid accumulation; (c) the ultrastructural morphology of mitochondria of mitochondria in well-differentiated BAT from pre-term infants can strictly resemble that found in active brown adipose tissue of adult phaeochromocytoma patients.


Subject(s)
Adipose Tissue/ultrastructure , Infant, Premature , Adult , Embryonic and Fetal Development , Female , Gestational Age , Humans , Infant, Newborn , Male , Microscopy, Electron , Pheochromocytoma/ultrastructure
20.
J Pediatr Surg ; 28(5): 735-7, 1993 May.
Article in English | MEDLINE | ID: mdl-8340871

ABSTRACT

Arterial occlusion not associated with umbilical artery catheterization is a rare condition in the newborn period. Two neonates with femoral and iliac artery occlusion in the first days of life are presented. While almost all the cases described in the literature underwent surgical treatment, these two infants received only pharmacological treatment with good results. Although angiography remains the examination of choice for the diagnosis, noninvasive angiologic evaluations such as oscillometry and Doppler flow examination have been used for both diagnosis and follow-up. The etiology in these two cases remains unknown. The results obtained with these two neonates suggest that with prompt recognition of this disorder and an aggressive medical treatment, a complete recovery could be achieved.


Subject(s)
Arterial Occlusive Diseases/drug therapy , Femoral Artery , Iliac Artery , Humans , Infant, Newborn , Male , Thrombolytic Therapy , Urokinase-Type Plasminogen Activator/therapeutic use , Verapamil/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL